Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr;36(4):358-66.
doi: 10.1111/j.1440-1681.2008.05071.x. Epub 2008 Oct 15.

Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects

Affiliations

Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects

Haroldo A Toque et al. Clin Exp Pharmacol Physiol. 2009 Apr.

Abstract

1. The anococcygeus muscle is part of the erectile machinery in male rodents. Phosphodiesterase (PDE) 5 inhibitors enhance and prolong the effects of cGMP, which has a key role in penile erection. The aim of the present study was to provide a functional and biochemical comparison of the three PDE5 inhibitors, namely sildenafil, tadalafil and vardenafil, in the rat anococcygeus muscle. 2. Muscle strips were mounted in 4 mL organ baths and isometric force recorded. Levels of cGMP were measured using an enzyme immunoassay kit. Western blots were used to determine PDE5 protein expression. 3. The PDE5 inhibitors concentration-dependently relaxed carbachol-precontracted anococcygeus muscle; however, vardenafil was more potent (pEC(50) = 8.11 +/- 0.05) than sildenafil (7.72 +/- 0.06) or tadalafil (7.69 +/- 0.05). Addition of N(G)-nitro-l-arginine methyl ester (100 micromol/L) or 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (10 micromol/L) to the organ baths caused significant rightward shifts in concentration-response curves for all PDE5 inhibitors. 4. Sildenafil, tadalafil and vardenafil (all at 0.1 micromol/L) caused leftward shifts in the glyceryl trinitrate (GTN) concentration-response curves (by 4.0-, 3.7- and 5.5-fold, respectively). In addition, all three PDE5 inhibitors significantly potentiated relaxation responses to both GTN (0.01-10 micromol/L) and electrical field stimulation (EFS; 1-32 Hz), with vardenafil having more pronounced effects. 5. All three PDE5 inhibitors reduced EFS-evoked contractions in a concentration-dependent manner over the concentration range 0.001-1 micromol/L. There were no significant differences between the effects of the three PDE5 inhibitors. 6. Vardenafil (0.01-0.1 micromol/L) was more potent in preventing cGMP degradation in vitro than sildenafil (0.01-0.1 micromol/L) and tadalafil (0.01-0.1 micromol/L). 7. Under control conditions, the expression of PDE5 was higher in the anococcygeus muscle than in the corpus cavernosum. 8. In conclusion, PDE5 inhibitors enhance exogenous and endogenous nitric oxide-mediated relaxation in the rat anococcygeus muscle. The potency of vardenafil was greater than that of either sildenafil or tadalafil.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effects of the phosphodiesterase (PDE) 5 inhibitors (a) sildenafil, (b) tadalafil and (c) vardenafil on the relaxations induced by glyceryl trinitrate (GTN) in rat anococcygeus muscle preparations. (●), control; (■), in the presence of 0.1 μmol/L PDE5 inhibitor. Muscles were precontracted with carbachol (10 μmol/L) and experimental values were calculated relative to the maximal changes from the contraction produced by carbachol in each tissue, which was taken as 100%. Data are the mean ± SEM (n = 5). *P < 0.05, **P < 0.01 compared with respective control values (Student’s t-test).
Fig. 2
Fig. 2
Effects of the phosphodiesterase (PDE) 5 inhibitors (a) sildenafil, (b) tadalafil and (c) vardenafil on electrical field stimulation (EFS)-induced relaxations of rat anococcygeus muscle strips precontracted with carbachol (10 μmol/L). (●), control; (■), in the presence of 0.1 μmol/L PDE5 inhibitor. Experimental values were calculated relative to the maximal changes from the contraction produced by carbachol in each tissue, which was taken as 100%. Data are the mean±SEM (n = 4–5). *P < 0.05, **P < 0.01 compared with respective control values (Student’s t-test).
Fig. 3
Fig. 3
Representative tracings of frequency-dependent relaxations to electrical field stimulation (EFS) in the absence and in the presence of the phosphodiesterase (PDE) 5 inhibitors (a) sildenafil, (b) tadalafil and (c) vardenafil (0.1 μmol/L; n = 4 each). Enhancement of the magnitude and duration of EFS-induced relaxations were observed in the presence of the PDE5 inhibitors. Nitrergic duration was determined as the time elapsed from 50% relaxation to 50% recovery.
Fig. 4
Fig. 4
Effect of increasing concentrations of sildenafil (●), tadalafil (■) and vardenafil (○) on the duration of nitrergic relaxations evoked by electrical field stimulation (EFS; 2 Hz, 50 V, 10 s trains every 90 s) in rat anococcygeus muscle strips contracted with carbachol (10 μmol/L). The duration of EFS-induced responses was determined as the time elapsed from 50% relaxation to 50% recovery. Data are the mean±SEM (n = 4). *P < 0.05 compared with sildenafil and tadalafil; P < 0.05 compared with tadalafil (one-way ANOVA followed by Student–Newman–Keuls’ post hoc test).
Fig. 5
Fig. 5
Effects of the phosphodiesterase (PDE) 5 inhibitors (a) sildenafil, (b) tadalafil and (c) vardenafil on the contractions induced by electrical field stimulation (EFS) in rat anococcygeus muscle preparations. (□), 0.001 μmol/L; (▨), 0.01 μmol/L; (■), 0.1 μmol/L; (▤), 1 μmol/L. Data were calculated relative to the contraction produced by each frequency of stimulation under control conditions (i.e. in the absence of inhibitor). Data are the mean±SEM.
Fig. 6
Fig. 6
Degradation of cGMP in the presence of rat anococcygeus cytosolic extracts in the absence or presence of (a) sildenafil, (b) tadalafil and (c) vardenafil. (●), control; (○), 0.001 μmol/L; (■), 0.01 μmol/L; (□), 0.1 μmol/L. Cyclic GMP (10 μmol/L) was incubated in the presence of cytosolic extract (30 μg protein) at 37°C (see Methods) and cyclic nucleotide content (expressed in μmol/L) was determined after 0, 5, 10 and 30 min of incubation. Data are the mean±SEM (n = 4). The dashed line represents the initial concentration of cGMP (10 μmol/L) for reference. The pIC50 values for sildenafil, tadalafil and vardenafil were 8.33 ± 0.07, 8.24 ± 0.08 and 8.75 ± 0.08, respectively.
Fig. 7
Fig. 7
Western blot analysis of phosphodiesterase (PDE) 5 in rat anococcygeus (AcM) and corpus cavernosum (CC). Marks indicate the approximate molecular weight. Tissue extracts were subjected to sodium dodecyl sulphate–polyacrylamide gel electrophoresis, followed by western blotting with anti-phosphodiesterase V antibody, as described in the Methods. Blots were detected with an Advance Chemiluminescence Detection Kit (n = 6). Summarized data of densitometrical analysis are also represented. Each set of determinations was performed in triplicate. H, human recombinant PDE5. **P < 0.01 compared with AcM (Student’s t-test).

Similar articles

Cited by

References

    1. Andersson KE, Persson K. Nitric oxide synthase and nitric oxide-mediated effects in lower urinary tract smooth muscles. World J Urol. 1994;12:274–80. - PubMed
    1. Gibson A. Phosphodiesterase 5 inhibitors and nitrergic transmission: From zaprinast to sildenafil. Eur J Pharmacol. 2001;411:1–10. - PubMed
    1. Toda N, Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev. 2003;55:271–324. - PubMed
    1. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev. 1995;75:191–236. - PubMed
    1. Andersson KE. Pharmacology of penile erection. Pharmacol Rev. 2001;53:417–50. - PubMed

Publication types

MeSH terms